Update on Hepatitis C Elimination in 2025 

Description

In this joint session with the European Society of Clinical Microbiology and Infectious Diseases Study Group for Viral Hepatitis, experts review and discuss the most updated information on hepatitis C elimination in the United States and other countries. Presenters explore obstacles to execution of hepatitis C elimination plans and strategies to overcome these challenges.

 

                                            

 

Journey Maps

Presentations

11:00 AM - 11:15 AM
Nov 08 2025
San Diego, CA

Hepatitis C Elimination in North America: What Should We Focus On?

Brian Conway, MD, FRCPC, Presenter
Hepatitis
11:15 AM - 11:30 AM
Nov 08 2025
San Diego, CA

Hepatitis C Elimination Across Continents: Successes, Challenges, and Lessons Learned

Oana Sandulescu, MD, PhD, Presenter
Hepatitis
11:30 AM - 11:45 AM
Nov 08 2025
San Diego, CA

Hepatitis C Virus Infection Among International Refugees and Immigrants

Norah Terrault, MD, MPH, FAASLD, Presenter
Hepatitis

Objectives

  • Discuss the status of national hepatitis C elimination programs in various countries.
  • Identify the obstacles to the hepatitis C elimination plans and outline opportunities for enhancing or developing the ongoing strategies.
  • Review the unique challenges that international refugees and immigrants face in accessing hepatitis C care and discuss strategies to overcome these barriers to care.
Chair

Harrys A. Torres, MD, FAASLD

The University of Texas MD Anderson Cancer Center